Drug and pharmaceutical recalls
17658 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-03-04FDA-DrugWizcure Pharmaa Private LimitedClass IIStop using Vista Gel eye drops
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugWizcure Pharmaa Private LimitedClass IIStop using Vista Tears eye drops
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- 2026-03-04FDA-DrugAgeboxClass IIStop using Agebox iKids-Growth Night Formula
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
- 2026-03-04FDA-DrugAgeboxClass IIStop using Agebox iKids-Growth capsules
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
- 2026-03-04FDA-DrugSlate Run PharmaceuticalsClass IIICheck Slate Run Eptifibatide Injection labeling
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.
- 2026-03-04FDA-DrugAvKAREClass IIStop using AvKARE Amantadine HCl capsules
Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
- 2026-03-04FDA-DrugLEO PHARMA INCClass IIStop using recalled Adbry injection lots
Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
- 2026-02-18FDA-DrugMcKessonClass ICheck your UDENYCA injection lot and serial number
Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.
- 2026-02-18FDA-DrugMeitheal Pharmaceuticals, IncClass IIStop using Meitheal Cetrorelix Acetate injection kits
Defective Delivery System: Missing or duplicated needles within the injection kit
- 2026-02-18FDA-DrugAmerisource Health Services LLCClass IICheck your oxycodone tablets for loose packaging
Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.
- 2026-02-18FDA-DrugFresenius Kabi Compounding, LLCClass IIStop using recalled Fresenius Kabi vancomycin injection
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugFresenius Kabi Compounding, LLCClass IIStop using Fresenius Kabi vancomycin HCl IV bags
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugFresenius Kabi Compounding, LLCClass IIDo not use Fresenius Kabi thiamine HCl injection
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugFresenius Kabi Compounding, LLCClass IIDo not use Fresenius Kabi ketamine HCl injection
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugFresenius Kabi Compounding, LLCClass IIDo not use Fresenius Kabi acyclovir sodium IV bags
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health hormone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health hormone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief